New brain tests aim to sharpen Alzheimer's prevention research

NCT ID NCT03900273

Terminated Knowledge-focused Sponsor: New York State Psychiatric Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study involves 400 healthy adults aged 60-85 to test new computerized measures of thinking and daily function. Participants are randomly assigned to take either the new tests or standard tests over one year. The goal is to see if the new tests are better at detecting changes without practice effects, which could improve future Alzheimer's prevention trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS

Contacts and locations

Show contact details

Locations

New York State Psychiatric Institute

New York, New York, 11032, United States
The Feinstein Institute for Medical Research

Manhasset, New York, 11030, United States
University of Miami

Miami, Florida, 33136, United States
University of Southern California

Los Angeles, California, 90033, United States